Proteins: emerging carrier for delivery of cancer therapeutics. - Wikidata - wikimedia - TriplyDB

Proteins: emerging carrier for delivery of cancer therapeutics.

Proteins: emerging carrier for delivery of cancer therapeutics.

http://www.wikidata.org/entity/Q38116070

about

Targeted Delivery of Amoxicillin to C. trachomatis by the Transferrin Iron Acquisition Pathway Quantification of recombinant immunotoxin delivery to solid tumors allows for direct comparison of in vivo and in vitro results.The application of monoclonal antibodies in cancer diagnosis.Interactive association of drugs binding to human serum albumin.Receptor-targeted drug delivery: current perspective and challenges.Albumin and its application in drug delivery.The future perspectives of natural materials for pulmonary drug delivery and lung tissue engineering.Gelatin-based particulate systems in ocular drug delivery.Antibody-targeted biodegradable nanoparticles for cancer therapy.Albumin nanostructures as advanced drug delivery systems.Evaluation of multimeric siRNA conjugates for efficient protamine-based delivery into breast cancer cells.A target-specific oral formulation of Doxorubicin-protein nanoparticles: efficacy and safety in hepatocellular cancer.Binding and Anticancer Properties of Plumbagin with Human Serum Albumin.Phase 1 dose-escalation study of mirvetuximab soravtansine (IMGN853), a folate receptor α-targeting antibody-drug conjugate, in patients with solid tumors.Green and facile synthesis of a theranostic nanoprobe with intrinsic biosafety and targeting abilities.Bio-Inspired Protein-Based Nanoformulations for Cancer Theranostics.

P2860

Q28550384-205CB111-1C26-4230-B0B2-4102DD0FF634 Q35786026-F39E798A-E436-4F8F-BAD0-405DD095DD22 Q38168870-35147C98-091F-4BD5-81CC-925FB9EA38D6 Q38192435-2C3AE575-AE6F-46F7-B7AD-B37723DC3E2B Q38265617-2BEE732B-C88A-484E-95A1-1E8AE80D7642 Q38292087-AB9E4576-9480-4F81-8D56-F1F122528CCE Q38293299-24CED473-933D-454F-94B3-5FF7C27562AA Q38310627-AEFCA21D-26CC-4B0B-A2D6-1DDBA40B08B7 Q38665261-4511A356-7F9F-4DDC-B5A6-223C6C1C0E22 Q38842596-4C8662D0-C76F-4470-8B02-33C9C949481F Q39009675-D1146B78-CF25-4238-BA59-BDD92B0775F4 Q42007121-34343F74-BD8D-4352-B4C3-6734CAABD58C Q46795399-6153CE3D-0958-48A8-94C9-B77EBAA3C4A7 Q48234647-4CC29C00-737E-4F8E-8EEE-FA51A483D094 Q49115686-AA4B38BB-559F-42CE-8D95-C16A9559C198 Q55024462-F905A1EA-8A9C-4E15-A4F0-62A0EFE8C656

P2860

Proteins: emerging carrier for delivery of cancer therapeutics.

http://www.wikidata.org/entity/Q38116070

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Proteins: emerging carrier for delivery of cancer therapeutics.

@en

type

label

Proteins: emerging carrier for delivery of cancer therapeutics.

@en

prefLabel

Proteins: emerging carrier for delivery of cancer therapeutics.

@en

P1433

Q38116070-DBCAB4F0-D211-40F5-B295-67DD3D84490B

P1476

Q38116070-4C2C3829-66C4-408C-A5E8-6C57DB9F6E6D

P2093

Q38116070-8D1C0EFA-8DC3-4DCA-98AA-93855BC05C8A

Q38116070-E6948B20-D6F9-492C-8660-C4C7BABFFAAB

P2860

Q38116070-0065FAB8-8534-4EB0-B3D2-85732DFA9D4F

Q38116070-02E86D51-3FA0-4CAA-B1D1-AC13BB0155B2

Q38116070-05394D8B-155A-4995-A571-9B060FC43C68

Q38116070-0A554F2D-2016-4ABA-B4DB-82DDC944F9D1

Q38116070-0B6B4FBC-F2E9-4B17-B829-C38F7F731646

Q38116070-0BAC46B4-C93F-4514-94C7-FEEBDF465896

Q38116070-0ED02B1E-A1C8-4C66-8E70-E6A040314B48

Q38116070-1290FEA6-61AB-44A5-BB3B-8B2ECCCF810B

Q38116070-2A82B209-4F1F-47FA-AC41-FB63AF049EF5

Q38116070-2AFFF288-3BC7-4B5C-9319-026EF362AB68

P304

Q38116070-E4F4ECAF-2DD4-41A9-95A7-BE7F7BA87C81

P31

Q38116070-9CBDF6D1-2014-4ACA-A050-E2299606DB29

P356

Q38116070-F3CD6A1B-BEE4-4EE6-8545-955DD505B0F4

P407

Q38116070-D5AD9F58-459D-4826-B013-A1735601AD16

P433

Q38116070-6FA4FDF7-9A54-451E-8ED5-A3FA44EE70B3

P478

Q38116070-C40CE337-3C49-4174-9A1C-DC8EA388DA43

P50

Q38116070-AD0CB3A3-72A4-4870-B84A-F3AE87533B6C

Q38116070-CDB83B9A-AE8E-4610-8F8D-BEB16AD01F29

P577

Q38116070-3DF7ED88-08B2-48C6-860C-DDC486E859B1

P698

Q38116070-268C6DA3-DA08-4004-B95B-F5EF8A575267

P356

17425247.2013.805200

P1433

Expert Opinion on Drug Delivery

P1476

Proteins: emerging carrier for delivery of cancer therapeutics

@en

P2093

Chetan Yewale

http://www.w3.org/2001/XMLSchema#string

Dipesh Baradia

http://www.w3.org/2001/XMLSchema#string

P2860

TIMP-2 fusion protein with human serum albumin potentiates anti-angiogenesis-mediated inhibition of tumor growth by suppressing MMP-2 expression

Maleimide-oligo(ethylene glycol) derivatives of camptothecin as albumin-binding prodrugs: synthesis and antitumor efficacy.

Highly specific HER2-mediated cellular uptake of antibody-modified nanoparticles in tumour cells.

Transferrin conjugates of doxorubicin: synthesis, characterization, cellular uptake, and in vitro efficacy.

Development of albumin-binding camptothecin prodrugs using a Peptide positional scanning library.

A phase II trial of methotrexate-human serum albumin (MTX-HSA) in patients with metastatic renal cell carcinoma who progressed under immunotherapy.

Phase II study of MTX-HSA in combination with cisplatin as first line treatment in patients with advanced or metastatic transitional cell carcinoma.

Targeting of albumin-embedded paclitaxel nanoparticles to tumors.

Effects of artemisinin-tagged holotransferrin on cancer cells.

Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G.

P304

1429-1448

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/17425247.2013.805200

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Ambikanandan Misra

P577

2013-06-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23789923

http://www.w3.org/2001/XMLSchema#string